Zinc-Mediated Binding of Nucleic Acids to Amyloid-β Aggregates: Role of Histidine Residues.

Amyloid-β peptide (Aβ) plays a central role in Alzheimer's disease (AD) pathogenesis. Besides extracellular Aβ, intraneuronal Aβ (iAβ) has been suggested to contribute to AD onset and development. Based on reported in vitro Aβ-DNA interactions and nuclear localization of iAβ, the interference of iAβ with the normal DNA expression has recently been proposed as a plausible pathway by which Aβ can exert neurotoxicity. Employing the sedimentation assay, thioflavin T fluorescence, and dynamic light scattering we have studied effects of zinc ions on binding of RNA and single- and double-stranded DNA molecules to Aβ42 aggregates. It has been found that zinc ions significantly enhance the binding of RNA and DNA molecules to pre-formed β-sheet rich Aβ42 aggregates. Another type of Aβ42 aggregates, the zinc-induced amorphous aggregates, was demonstrated to also bind all types of nucleic acids tested. To evaluate the role of the Aβ metal-binding domain's histidine residues in Aβ-nucleic acid interactions mediated by zinc, Aβ16 mutants with substitutions H6R and H6A-H13A and rat Aβ16 lacking histidine residue 13 were used. The zinc-induced interaction of Aβ16 with DNA was shown to critically depend on histidine residues 6 and 13. However, the inclusion of H6R mutation in Aβ42 peptide did not affect DNA binding to Aβ42 aggregates. Since oxidative and/or nitrosative stresses implicated in AD pathogenesis are known to release zinc ions from metallothioneins in cytoplasm and cell nuclei, our findings suggest that intracellular zinc can be an important player in iAβ-nucleic acid interactions.

[1]  A. Makarov,et al.  Interplay of histidine residues of the Alzheimer’s disease Aβ peptide governs its Zn-induced oligomerization , 2016, Scientific Reports.

[2]  M. Mann,et al.  Cytoplasmic protein aggregates interfere with nucleocytoplasmic transport of protein and RNA , 2016, Science.

[3]  G. Kim,et al.  The Role of Oxidative Stress in Neurodegenerative Diseases , 2015, Experimental neurobiology.

[4]  A. Makarov,et al.  Tyrosine Based Electrochemical Analysis of Amyloid-β Fragment (1-16) Binding to Metal(II) Ions , 2015 .

[5]  N. Andreasen,et al.  Pathways to Alzheimer's disease , 2014, Journal of internal medicine.

[6]  A. Bush,et al.  Metallostasis in Alzheimer's disease. , 2013, Free radical biology & medicine.

[7]  P. Faller,et al.  Role of metal ions in the self-assembly of the Alzheimer's amyloid-β peptide. , 2013, Inorganic chemistry.

[8]  A. Barrantes,et al.  Specific binding of DNA to aggregated forms of Alzheimer's disease amyloid peptides. , 2013, International journal of biological macromolecules.

[9]  P. Tsvetkov,et al.  Zinc-induced interaction of the metal-binding domain of amyloid-β peptide with DNA. , 2013, Journal of Alzheimer's disease : JAD.

[10]  Veer Bala Gupta,et al.  Studies on the mechanism of the DNA nicking property of amyloid-β40: implications in Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.

[11]  T. Bayer,et al.  Intraneuronal Aβ accumulation and neurodegeneration: lessons from transgenic models. , 2012, Life sciences.

[12]  Ruth Nussinov,et al.  Metal binding sites in amyloid oligomers: Complexes and mechanisms , 2012 .

[13]  A. Barrantes,et al.  Alzheimer's disease amyloid peptides interact with DNA, as proved by surface plasmon resonance. , 2012, Current Alzheimer research.

[14]  L. Hemmingsen,et al.  Rapid exchange of metal between Zn(7)-metallothionein-3 and amyloid-β peptide promotes amyloid-related structural changes. , 2012, Biochemistry.

[15]  P. Tsvetkov,et al.  NMR solution structure of rat aβ(1-16): toward understanding the mechanism of rats' resistance to Alzheimer's disease. , 2012, Biophysical journal.

[16]  D. Bhowmik,et al.  Zn(++) binding disrupts the Asp(23)-Lys(28) salt bridge without altering the hairpin-shaped cross-β Structure of Aβ(42) amyloid aggregates. , 2011, Biophysical journal.

[17]  Bryan Maloney,et al.  The Alzheimer's amyloid β-peptide (Aβ) binds a specific DNA Aβ-interacting domain (AβID) in the APP, BACE1, and APOE promoters in a sequence-specific manner: characterizing a new regulatory motif. , 2011, Gene.

[18]  P. Tsvetkov,et al.  Zinc-induced dimerization of the amyloid-β metal-binding domain 1-16 is mediated by residues 11-14. , 2011, Molecular bioSystems.

[19]  L. Jungbauer,et al.  Preparing synthetic Aβ in different aggregation states. , 2011, Methods in molecular biology.

[20]  Alexander A. Makarov,et al.  Minimal Zn(2+) binding site of amyloid-β. , 2010, Biophysical journal.

[21]  Gabriele Meloni,et al.  Zinc release of Zn₇-metallothionein-3 induces fibrillar type amyloid-β aggregates. , 2010, Metallomics : integrated biometal science.

[22]  X. Qu,et al.  Alzheimer's disease amyloid beta converting left-handed Z-DNA back to right-handed B-form. , 2010, Chemical communications.

[23]  Bryan Maloney,et al.  Beyond the signaling effect role of amyloid-β42 on the processing of APP, and its clinical implications , 2010, Experimental Neurology.

[24]  Ruth Nussinov,et al.  Zinc ions promote Alzheimer Aβ aggregation via population shift of polymorphic states , 2010, Proceedings of the National Academy of Sciences.

[25]  E. Capetillo-Zarate,et al.  Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease , 2010, Acta Neuropathologica.

[26]  J. S. Jiménez Protein-DNA interaction at the origin of neurological diseases: a hypothesis. , 2010, Journal of Alzheimer's disease : JAD.

[27]  Y. Ohyagi Intracellular amyloid beta-protein as a therapeutic target for treating Alzheimer's disease. , 2008, Current Alzheimer research.

[28]  Valerio Frazzini,et al.  Altered oxidant-mediated intraneuronal zinc mobilization in a triple transgenic mouse model of Alzheimer’s disease , 2008, Experimental Gerontology.

[29]  A. Cuello,et al.  Impact of Intracellular β-Amyloid in Transgenic Animals and Cell Models , 2008, Neurodegenerative Diseases.

[30]  Charles P. Fontaine,et al.  Insights into Zn2+ homeostasis in neurons from experimental and modeling studies. , 2008, American journal of physiology. Cell physiology.

[31]  R. Ravid,et al.  First evidence for helical transitions in supercoiled DNA by amyloid β peptide (1–42) and aluminum , 2004, Journal of Molecular Neuroscience.

[32]  X. Qu,et al.  Time-Dependent DNA Condensation Induced by Amyloid β-Peptide , 2007 .

[33]  A. Barrantes,et al.  Interaction between Alzheimer's Abeta1-42 peptide and DNA detected by surface plasmon resonance. , 2007, Journal of Alzheimer's disease : JAD.

[34]  A. Mazur,et al.  Structural Changes of Region 1-16 of the Alzheimer Disease Amyloid β-Peptide upon Zinc Binding and in Vitro Aging* , 2006, Journal of Biological Chemistry.

[35]  T. Tabira,et al.  Intracellular Aβ42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease , 2005 .

[36]  E. Iseki,et al.  Nitric oxide pathways in Alzheimer's disease and other neurodegenerative dementias , 2004, Neurological research.

[37]  C. Suschek,et al.  Regulation of zinc homeostasis by inducible NO synthase-derived NO: Nuclear metallothionein translocation and intranuclear Zn2+ release , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[38]  R. Tikkanen,et al.  Cytosolic and nuclear aggregation of the amyloid β-peptide following its expression in the endoplasmic reticulum , 2002, Histochemistry and Cell Biology.

[39]  M. D'Andrea,et al.  Intracellular accumulation of β-amyloid1–42 in neurons is facilitated by the α7 nicotinic acetylcholine receptor in Alzheimer’s disease , 2002, Neuroscience.

[40]  P. A. Peterson,et al.  Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease , 2001, Histopathology.

[41]  P. Fraser,et al.  Effect of amino-acid substitutions on Alzheimer's amyloid-beta peptide-glycosaminoglycan interactions. , 2000, European journal of biochemistry.

[42]  B. Shin,et al.  Detection of β-Amyloid Peptide Aggregation Using DNA Electrophoresis , 2000 .

[43]  G. Lees,et al.  Nitric oxide generators produce accumulation of chelatable zinc in hippocampal neuronal perikarya , 1998, Brain Research.

[44]  D. Selkoe,et al.  Heparin-binding properties of the amyloidogenic peptides Abeta and amylin. Dependence on aggregation state and inhibition by Congo red. , 1997, The Journal of biological chemistry.

[45]  Zhi-Xin Wang,et al.  A novel two‐site binding equation presented in terms of the total ligand concentration , 1996, FEBS letters.

[46]  D. Williams,et al.  Nuclear and cytoplasmic localization of the beta-amyloid peptide (1-43) in transfected 293 cells. , 1996, Biochemical and biophysical research communications.

[47]  H. Wiśniewski,et al.  Amyloid protein and neurofibrillary tangles coexist in the same neuron in Alzheimer disease. , 1989, Proceedings of the National Academy of Sciences of the United States of America.